Navigation Links
'Translational Research: From Bench to Bedside' Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation
Date:9/14/2009

Briefing is the second in a three-part series on "Achieving Recovery Through Discovery"

WASHINGTON, Sept. 14 /PRNewswire-USNewswire/ -- The Council for American Medical Innovation will host a breakfast briefing on Capitol Hill titled "Translational Research - From Bench to Bedside." Health policy experts will explore important changes needed to improve the process of development and approval for safe and effective drugs, biologics, medical devices and diagnostics. The Council believes a robust infrastructure for translational research that transforms clinical research into practical treatments quickly and efficiently is critical to ensuring new, life-saving medical treatments reach the market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO )

This is the second in a three-part briefing series examining the role of public policy in promoting medical innovation to help our nation recover from health and economic crises. For details on other briefings, visit: www.americanmedicalinnovation.org.

WHO: Remarks by:

  • Amy Comstock Rick, CEO of the Parkinson's Action Network
  • The Honorable Patrick Kennedy, U.S. Representative (D-RI) (invited)
  • Debra Lappin, President of the Council for American Medical Innovation
  • Alan Leshner, Ph.D., President of the American Association for the Advancement of Science (AAAS)
  • Lesa Mitchell, Vice President of the Ewing Marion Kauffman Foundation

*Debra Lappin and other panelists will be available for media interviews between 10:00 and 10:30 a.m. Please contact Laura Lowery, 206-799-5604 to secure an interview.

WHERE: Rayburn House Office Building, Room B338

WHEN: Thursday, September 17, 2009

8:30 - 10:00 a.m.

RSVP: http://www.regonline.com/recoverythroughdiscovery

About the Council for American Medical Innovation

The United States faces serious challenges to maintaining its leadership position in innovation. The Council for American Medical Innovation is bringing together leaders in research, medicine, public health, academia, education, labor, and business, who are working in partnership toward a national policy agenda aimed at preserving U.S. leadership in medical innovation. American medical innovators create millions of high-paying jobs, and their discoveries are integral in the fight to cure cancer and other illnesses. The Council for American Medical Innovation views leadership in medical innovation as a key part of America's economic recovery, future prosperity and health.

For more information on the Council for American Medical Innovation, visit www.americanmedicalinnovation.org.


'/>"/>
SOURCE Council for American Medical Innovation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ASH and EHA Jointly Announce Translational Research Training in Hematology Program
2. ASH and EHA jointly announce translational research training in hematology program
3. EAU Research Foundation organizes meeting in Amsterdam highlighting translational research results
4. Crescendo(tm), the Clinical and Translational Research Exchange, is Launched
5. Van Andel Research Institute of Michigan and Translational Genomics Research Institute of Arizona Undertake Unprecedented Alliance to Promote Science and Health
6. OnCore System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research
7. Rockefeller Universitys Center for Clinical and Translational Science funds 18 new pilot studies
8. URMC Breaks Ground for New Translational Research Institute
9. Scripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer
10. Temple, Fox Chase and Geisinger create Keystone Institute for Translational Medicine
11. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... Fairfax, VA (PRWEB) , ... May 26, 2017 ... ... is pleased to announce a new educational seminar to focus on current legislative ... Regulatory News(LEARN) seminar will begin at 1 p.m. Sunday, Sept. 10, and will ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... copper, antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie ... are thrilled to partner with Cupron® to provide customers with a game changing ...
(Date:5/26/2017)... , ... May 26, 2017 , ... Rob Lowe acts ... upcoming production of the series is on hiking in American. Viewers can reconnect with ... the great benefits of hiking. , Many consumers have looked for an inventive new ...
(Date:5/26/2017)... ... ... “Just What Happened in the Garden of Eden”: retells the stories of three Bible figures ... of published author, Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. ... three. At six, they moved to Dayton, Ohio, where Penny graduated high school. ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD is dual board ... He is known for his distinguished expertise and experience in the diagnosis and treatment ... training in treating renovascular disease and aortic aneurysm . He is known for ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 9, 2017  Semler Scientific, Inc. (OTCQB: SMLR), ... to improve the clinical effectiveness and efficiency of ... first quarter ended March 31, 2017. ... customers to identify when preventive care options are ... like heart attacks or strokes occur," said ...
(Date:5/6/2017)... Provista , a proven leader in the supply chain industry ... Jim Cunniff as the company,s new president and CEO. ... Provista, including most recently serving as the president and CEO ... He assumed his new role with Provista on May 1, ... says Jody Hatcher , president, Sourcing and Collaboration Services ...
(Date:5/4/2017)... 4, 2017  Fortuna Fix Inc. (" Fortuna "), ... first to eliminate the need for embryonic and fetal stem ... neurodegenerative diseases. Fortuna announced today the ... Michael Fehlings , MD, PhD; Father Kevin FitzGerald , ... and Professor James Giordano , PhD. "We ...
Breaking Medicine Technology: